Overall, these results demonstrate that the impact of these two mutants on the chemosensitivity of glioma to TMZ and CAPE correlates with the degree of alteration in their binding and transport functions, highlighting GLUT3’s role in enhancing GBM chemosensitivity by direct binding and transport of these drugs. This evidence concerns the gene SLC2A3 and central nervous system cancer.